IP Library Granted Patent US 8,497,124
Granted Patent B2
US 8,497,124 · App. 13/465,490 · Granted Jul 30, 2013

Methods and products for reprogramming cells to a less differentiated state

Inventors: Matthew Angel (Cambridge, MA); Christopher Rohde (Cambridge, MA)
Assignee: Factor Bioscience Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,497,124
App. No.
13/465,490
Granted
Jul 30, 2013
Kind
B2
Abstract

The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.

Claims (20)

1. A method for reprogramming a cell to a less differentiated state, comprising:

a. culturing a differentiated cell with a reprogramming medium containing albumin, wherein the albumin is treated with an ion-exchange resin or charcoal;

b. transfecting the cell with one or more synthetic RNA molecules, wherein the one or more synthetic RNA molecules includes at least one RNA molecule encoding one or more reprogramming factors and wherein the transfecting results in the cell expressing the one or more reprogramming factors; and

c. repeating step (b) at least twice during 5 consecutive days to result in the cell being reprogrammed to a less differentiated state.

2. The method of claim 1 , wherein the albumin was treated with sodium octanoate.

3. The method of claim 2 , wherein the albumin was brought to a temperature of at least 40° C.

4. The method of claim 1 , wherein the one or more synthetic RNA molecules includes at least one RNA molecule encoding at least one member of the group: Oct4 protein, Sox2 protein, Klf4 protein, and c-Myc protein.

5. The method of claim 1 , wherein the one or more synthetic RNA molecules includes at least one RNA molecule encoding Oct4 protein, at least one RNA molecule encoding Sox2 protein, at least one RNA molecule encoding Klf4 protein, and at least one RNA molecule encoding c-Myc protein.

6. The method of claim 1 , further comprising contacting the cell with at least one member of the group: poly-L-lysine, poly-L-ornithine, RGD peptide, fibronectin, vitronectin, collagen, and laminin.

7. The method of claim 1 , wherein the one or more synthetic RNA molecules contains at least one member of the group: a pseudouridine residue and a 5-methylcytidine residue.

8. The method of claim 1 , wherein the cell is a skin cell.

9. A method for reprogramming a cell to a less differentiated state, comprising:

a. culturing a differentiated cell with a reprogramming medium containing albumin, wherein the albumin is treated with sodium octanoate; brought to a temperature of at least 40° C.; and treated with an ion-exchange resin or charcoal;

b. transfecting the cell with one or more synthetic RNA molecules, wherein the one or more synthetic RNA molecules includes at least one RNA molecule encoding one or more reprogramming transcription factors and wherein the transfecting results in the cell expressing the one or more synthetic RNA molecules; and

c. repeating step (b) at least twice during 5 consecutive days to result in the cell being reprogrammed to a less differentiated state.

10. The method of claim 9 , wherein the one or more synthetic RNA molecules includes at least one RNA molecule encoding at least one member of the group: Oct4 protein, Sox2 protein, Klf4 protein, and c-Myc protein.

11. The method of claim 9 , wherein one or more synthetic RNA molecules includes at least one RNA molecule encoding Oct4 protein, at least one RNA molecule encoding Sox2 protein, at least one RNA molecule encoding Klf4 protein, and at least one RNA molecule encoding c-Myc protein.

12. The method of claim 9 , further comprising contacting the cell with at least one member of the group: poly-L-lysine, poly-L-ornithine, RGD peptide, fibronectin, vitronectin, collagen, and laminin.

13. The method of claim 9 , wherein the one or more synthetic RNA molecules contains at least one member of the group: a pseudouridine residue and a 5-methylcytidine residue.

14. The method of claim 9 , wherein the cell is a skin cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2016
From: ANGEL, MATTHEW; ROHDE, CHRISTOPHER
To: FACTOR BIOSCIENCE INC.
Reel/Frame 040350/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: ANGEL, MATTHEW; ROHDE, CHRISTOPHER
To: FACTOR BIOSCIENCE INC.
Reel/Frame 029412/0372 →
Continuity (4)
Provisional Application 61637570 · Apr 24, 2012
Provisional Application 61569595 · Dec 12, 2011
Provisional Application 61566948 · Dec 5, 2011
Related Publication 20130029418A1 · Jan 31, 2013